Serum level of IFNβ distinguishes early from late relapses after biologics withdrawal in rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1038/s41598-022-21160-0
Published Online: 2022-10-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sakashita, Eiji
Nagatani, Katsuya
Endo, Hitoshi
Minota, Seiji
Text and Data Mining valid from 2022-10-03
Version of Record valid from 2022-10-03
Article History
Received: 25 March 2022
Accepted: 23 September 2022
First Online: 3 October 2022
Competing interests
: The authors declare no competing interests.